Literature DB >> 25670333

Apolipoprotein E ε4 genotype and the temporal relationship between depression and dementia.

Ida K Karlsson1, Anna M Bennet1, Alexander Ploner1, Therese M-L Andersson1, Chandra A Reynolds2, Margaret Gatz3, Nancy L Pedersen4.   

Abstract

To investigate how apolipoprotein E (APOE) affects the temporal relationship between depression and dementia, we conducted a nested case-control study with longitudinal depression and dementia evaluations from several population studies by using 804 dementia cases and 1600 matched controls, totaling 1519 unique individuals. Depression within 10 years of onset of dementia was strongly associated with dementia diagnosis regardless of APOE status (incidence rate ratio [IRR] 5.25, 95% confidence interval [95% CI] 3.32-8.31 for ε4 carriers, IRR 4.40, 95%CI 3.23-5.99 for noncarriers). However, we found a significant interaction between depression more than 10 years before the onset of dementia and APOE (p = 0.01), with depression more distal to dementia being a risk factor only in ε4 carriers (IRR 3.39, 95% CI 1.69-6.78 for carriers, IRR 1.01, 95% CI 0.60-1.70 for noncarriers). Thus, depression with onset close in time to dementia onset is associated with disease irrespective of APOE genotype, whereas depression more distal to dementia onset is a risk factor only in ε4-carriers. This is the first study to show the interaction between APOE and depression to be dependent on timing of depression onset.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Apolipoprotein E; Dementia; Depression

Mesh:

Substances:

Year:  2015        PMID: 25670333      PMCID: PMC4380668          DOI: 10.1016/j.neurobiolaging.2015.01.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  28 in total

Review 1.  History of depression as a risk factor for dementia: an updated review.

Authors:  A F Jorm
Journal:  Aust N Z J Psychiatry       Date:  2001-12       Impact factor: 5.744

2.  Telephone screening to identify potential dementia cases in a population-based sample of older adults.

Authors:  Margaret Gatz; Chandra A Reynolds; Richard John; Boo Johansson; James A Mortimer; Nancy L Pedersen
Journal:  Int Psychogeriatr       Date:  2002-09       Impact factor: 3.878

3.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

4.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins.

Authors:  M Gatz; N L Pedersen; S Berg; B Johansson; K Johansson; J A Mortimer; S F Posner; M Viitanen; B Winblad; A Ahlbom
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1997-03       Impact factor: 6.053

5.  The Swedish Twin Registry: establishment of a biobank and other recent developments.

Authors:  Patrik K E Magnusson; Catarina Almqvist; Iffat Rahman; Andrea Ganna; Alexander Viktorin; Hasse Walum; Linda Halldner; Sebastian Lundström; Fredrik Ullén; Niklas Långström; Henrik Larsson; Anastasia Nyman; Clara Hellner Gumpert; Maria Råstam; Henrik Anckarsäter; Sven Cnattingius; Magnus Johannesson; Erik Ingelsson; Lars Klareskog; Ulf de Faire; Nancy L Pedersen; Paul Lichtenstein
Journal:  Twin Res Hum Genet       Date:  2012-11-09       Impact factor: 1.587

6.  Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study.

Authors:  Margaret Gatz; Laura Fratiglioni; Boo Johansson; Stig Berg; James A Mortimer; Chandra A Reynolds; Amy Fiske; Nancy L Pedersen
Journal:  Neurobiol Aging       Date:  2005-04       Impact factor: 4.673

Review 7.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

Review 8.  Depression and risk of developing dementia.

Authors:  Amy L Byers; Kristine Yaffe
Journal:  Nat Rev Neurol       Date:  2011-05-03       Impact factor: 42.937

9.  Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors.

Authors:  Xiangfei Meng; Carl D'Arcy
Journal:  Int J Geriatr Psychiatry       Date:  2012-12-17       Impact factor: 3.485

10.  Apolipoprotein e4 genotype and depressive symptoms as risk factors for dementia in an older korean population.

Authors:  Jae-Min Kim; Seon-Young Kim; Kyung-Yeol Bae; Sung-Wan Kim; Il-Seon Shin; Su-Jin Yang; Young-Heon Song; Jin-Sang Yoon
Journal:  Psychiatry Investig       Date:  2010-05-04       Impact factor: 2.505

View more
  9 in total

1.  Trajectories of Depressive Symptoms in Older Adults and Risk of Dementia.

Authors:  Allison R Kaup; Amy L Byers; Cherie Falvey; Eleanor M Simonsick; Suzanne Satterfield; Hilsa N Ayonayon; Stephen F Smagula; Susan M Rubin; Kristine Yaffe
Journal:  JAMA Psychiatry       Date:  2016-05-01       Impact factor: 21.596

Review 2.  A Review on the General Stability of Mood Disorder Diagnoses Along the Lifetime.

Authors:  Diego de la Vega; Ana Piña; Francisco J Peralta; Sam A Kelly; Lucas Giner
Journal:  Curr Psychiatry Rep       Date:  2018-04-02       Impact factor: 5.285

3.  Gene-Environment Interplay in Physical, Psychological, and Cognitive Domains in Mid to Late Adulthood: Is APOE a Variability Gene?

Authors:  Chandra A Reynolds; Margaret Gatz; Kaare Christensen; Lene Christiansen; Anna K Dahl Aslan; Jaakko Kaprio; Tellervo Korhonen; William S Kremen; Robert Krueger; Matt McGue; Jenae M Neiderhiser; Nancy L Pedersen
Journal:  Behav Genet       Date:  2015-11-04       Impact factor: 2.805

4.  APOE ε4 associated with preserved executive function performance and maintenance of temporal and cingulate brain volumes in younger adults.

Authors:  Warren D Taylor; Brian Boyd; Rachel Turner; Douglas R McQuoid; Allison Ashley-Koch; James R MacFall; Ayman Saleh; Guy G Potter
Journal:  Brain Imaging Behav       Date:  2017-02       Impact factor: 3.978

5.  Feelings of Hopelessness in Midlife and Cognitive Health in Later Life: A Prospective Population-Based Cohort Study.

Authors:  Krister Håkansson; Hilkka Soininen; Bengt Winblad; Miia Kivipelto
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

6.  Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational Studies.

Authors:  Yao-Chin Wang; Po-An Tai; Tahmina Nasrin Poly; Md Mohaimenul Islam; Hsuan-Chia Yang; Chieh-Chen Wu; Yu-Chuan Jack Li
Journal:  Behav Neurol       Date:  2018-07-10       Impact factor: 3.342

7.  Apolipoprotein E Homozygous ε4 Allele Status: A Deteriorating Effect on Visuospatial Working Memory and Global Brain Structure.

Authors:  Janik Goltermann; Ronny Redlich; Katharina Dohm; Dario Zaremba; Jonathan Repple; Claas Kaehler; Dominik Grotegerd; Katharina Förster; Susanne Meinert; Verena Enneking; Emily Schlaghecken; Lara Fleischer; Tim Hahn; Harald Kugel; Andreas Jansen; Axel Krug; Katharina Brosch; Igor Nenadic; Simon Schmitt; Frederike Stein; Tina Meller; Dilara Yüksel; Elena Fischer; Marcella Rietschel; Stephanie H Witt; Andreas J Forstner; Markus M Nöthen; Tilo Kircher; Anbupalam Thalamuthu; Bernhard T Baune; Udo Dannlowski; Nils Opel
Journal:  Front Neurol       Date:  2019-05-27       Impact factor: 4.003

Review 8.  Psychiatric disorders and risk of subsequent dementia: Systematic review and meta-analysis of longitudinal studies.

Authors:  Jean Stafford; Wing Tung Chung; Andrew Sommerlad; James B Kirkbride; Robert Howard
Journal:  Int J Geriatr Psychiatry       Date:  2022-04-11       Impact factor: 3.850

9.  Apolipoprotein E genotype does not moderate the associations of depressive symptoms, neuroticism and allostatic load with cognitive ability and cognitive aging in the Lothian Birth Cohort 1936.

Authors:  Zander Crook; Tom Booth; Simon R Cox; Janie Corley; Dominika Dykiert; Paul Redmond; Alison Pattie; Adele M Taylor; Sarah E Harris; John M Starr; Ian J Deary
Journal:  PLoS One       Date:  2018-02-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.